Interleukin-12 as a veterinary vaccine adjuvant
CA 2457563 A1 · Owner: Wyeth · Inventors: Chu, Hsien-Jue
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
This disclosure describes a composition for enhancing the immunogenicity of a veterinary vaccine that comprises a pharmacologically effective amount of an immunomodulator and an immunoadjuvant. Additionally the disclosure describes , a vaccine composition comprising an effective immunizing amount of an antigen an immunomodulator, an immunoadjuvant and a pharmaceutically acceptable carrier. The compositions may optionally contain conventional secondary , adjuvants or preservatives. The disclosure further describes a unique method for enhancing or accelerating the immunogenicity of weak immunosuppressive or , marginally safe antigens by administering to an avian or mammalian species a …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 13, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended September 13, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 13, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.